• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Business/Financial News

Integrity Applications inks exclusive Dutch distro deal for GlucoTrack

December 28, 2017 By Fink Densford

Integrity Applications

Integrity Applications said today it inked an exclusive distribution deal with MediReva B.V. to distribute its GlucoTrack non-invasive glucose measuring device in the Netherlands, effective December 22. Integrity Application’s flagship GlucoTrack is a sensor that clips to the earlobe and uses a combination of metrics to determine blood glucose based on physiological changes in the body. […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: integrityapplications

Beta Bionics raises $2m

December 28, 2017 By Fink Densford

Beta Bionics

Beta Bionics has raised $2.4 million in a new round of equity and securities financing, according to an SEC filing posted this week. A total of 11 anonymous investors have participated in the round, though the company has not yet stated who has joined or how it plans to spend funds raised. The company is […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Beta Bionics

Medherant raises $5m to move transdermal ibuprofen patch to clinical trials

December 12, 2017 By Fink Densford

Medherant

Transdermal drug-delivery company Medherant said yesterday it raised $5.1 million (GBP £3.8 million) in a funding round as it looks to move its drug-delivering ibuprofen Tepi Patch into clinical development early next year. The funding round was led by majority shareholder Mercia Technologies and joined by existing shareholders and new private investors, the Coventry, U.K.-based […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Pain Management, Pharmaceuticals Tagged With: medherant

Medtech stories we missed this week: Dec. 8, 2017

December 8, 2017 By Danielle Kirsh

medtech missed

From Minimus Spine’s European distribution deal to Stimwave receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Minimus Spine inks EU distribution deal Minimus Spine announced in a Dec. 4 press release that it has signed its first European distribution deal with Italian company Moss […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Featured, Food & Drug Administration (FDA), Oncology, Pain Management, Regulatory/Compliance, Surgical, Technology Tagged With: Cagent Vascular, CSA Medical, Dermacon, Elanix, InspireMD, Life Spine Inc., medtech, Minimus Spine, Stimwave

These 10 medtech companies care a lot about research

November 29, 2017 By Chris Newmarker

Among the world’s largest medtech companies, these 10 spent the largest portion of their budgets on research and development. So what have they produced? Every year, Medical Design & Outsourcing pulls financial regulatory filings and reaches out to major, companies in some cases to create a list of the 100 largest medical device companies in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Research & Development Tagged With: abiomed, Big 100, biomerieux, DexCom Inc., Insulet, Royal Philips, Spectranetics

Wearable CGM biosensor dev BioLinq raises $10m

November 27, 2017 By Fink Densford

Biolinq

Biosensor developer Biolinq said today it closed a $10 million Series A financing round to support its wirelessly-enabled biosensor patch designed for continuous monitoring of biomarkers, with an initial focus on monitoring glucose in diabetes patients. The round was led by M Ventures in collaboration with Hikma Ventures and joined by Grey Sky Venture Partners, […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring Tagged With: biolinq

Medtech stories we missed this week: Nov. 17, 2017

November 17, 2017 By Danielle Kirsh

missed medtech

From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Implants, mHealth (Mobile Health), Neurological, Regulatory/Compliance, Research & Development Tagged With: Helomics, InnerScope, iReliev, LensAR Inc., medtech, Mevion Medical Systems, Mortise Medical, Nexstim, Skyline Medical

Propeller Health, Express Scripts ink smart inhaler sensor deal

November 16, 2017 By Fink Densford

Propeller Health, Express Scripts

Propeller Health said today it inked a strategic partnership deal with Express Scripts (NSDQ:ESRX) to provide Propeller’s digital solutions to Express Script members. Through the deal, St. Louis-based Express Script members will be able to use inhaler sensors and connected mobile applications to manage their asthma or chronic obstructive pulmonary disease. The companies touted it as the largest […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Express Scripts, Propeller Health

MediWound raises $25m

October 27, 2017 By Fink Densford

MediWound touts Phase II study

MediWound (NSDQ:MDWD) today announced a $25.2 million offering to support research and development of its EscharEx topical biological drug for debridement of chronic and other hard-to-heal wounds. In the offering, the Israel-based company floated approximately 5 million shares, including 637,664 shares through an underwriter’s option, according to an SEC filing. Cowen & Company and Wells Fargo […]

Filed Under: Business/Financial News, Pharmaceuticals, Wound Care Tagged With: MediWound

Medtech stories we missed this week: Oct. 27, 2017

October 27, 2017 By Danielle Kirsh

missedmedtech-1027

From RadiaDyne’s FDA expansion to NuVasive launching its new implants, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA expands indications for RadiaDyne’s OARtrac dose monitor RadiaDyne announced in an Oct. 24 press release that it has received additional FDA clearance for its upcoming OARtrac. The OARtrac allows […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Neurological, Radiosurgery, Regulatory/Compliance Tagged With: Alcyone Lifesciences, Implanet, medtech, nuvasive, Ortek Therapeutics, radiadyne, Tau Consortium, Varian Medical Systems

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Go to page 76
  • Go to page 77
  • Interim pages omitted …
  • Go to page 89
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS